Extensive venous and arterial thrombosis associated with an inhibitor to activated protein C. Blood.
Lack of activated protein C resistance in healthy Hong Kong Chinese blood donors: correlation with absence of Arg506-Gln mutation of factor V gene [letter].
Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women.
Activated protein C resistance assay performance: improvement by sample dilution with factor V--deficient plasma.
Resistance to activated protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis: functional tests and DNA-based assays, pros and cons.
Influence of storage conditions on activated protein C resistance assay [letter].
A new dilution for the modified APTT-based assay for activated protein C resistance: improvement of the reliability in patients with a lupus anticoagulant.